Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-01-30

FDA Approved: RISPERIDONE — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application for a generic risperidone product from Amneal Pharmaceuticals LLC. Risperidone is an antipsychotic indicated for sch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISPERIDONE (RISPERIDONE)

Snippet

SUPPL AP for RISPERIDONE (RISPERIDONE)